Microbial compositions and methods of use for canine enteropathy and dysbiosis
US12180464B2 · kind B2 · utility
0Cited by
19References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 2022 |
| Grant date | Dec 31, 2024 |
| Priority date | — |
| Expiry date | Aug 10, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldFood chemistry
- WIPO sectorChemistry
Abstract
The disclosure relates to isolated microorganisms—including novel strains of the microorganisms—microbial ensembles, and compositions comprising the same. Furthermore, the disclosure teaches methods of utilizing the described microorganisms, microbial compositions, and compositions comprising the same, in methods for treating or preventing gastrointestinal enteropathy or dysbiosis in canines. In particular aspects, the disclosure provides methods of treating or preventing morbidity and mortality caused by GI pathogenesis or autoimmunity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.